Connection

Helmut Albrecht to Dideoxynucleosides

Back to Details
This is a "connection" page, showing publications Helmut Albrecht has written about Dideoxynucleosides.
Helmut Albrecht
Connection Strength
0.028
Dideoxynucleosides
  1. Once-daily dolutegravir versus twice-daily raltegravir in antiretroviral-naive adults with HIV-1 infection (SPRING-2 study): 96 week results from a randomised, double-blind, non-inferiority trial. Lancet Infect Dis. 2013 Nov; 13(11):927-35.
    View in: PubMed
    Score: 0.028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.